Admission Prevention in COPD: Non-pharmacological Management

Overview

Journal BMC Med

Publisher Biomed Central

Specialty General Medicine

Date 2013 Nov 21

PMID 24252219

Citations 8

Authors

Eui-Sik Suh

Swapna Mandal

Nicholas Hart

Affiliations

Soon will be listed here.

Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) are one of the commonest causes of hospital admission in Europe, Australasia, and North America. These adverse events have a large effect on the health status of the patients and impose a heavy burden on healthcare systems. While we acknowledge the contribution of pharmacotherapies to exacerbation prevention, our interpretation of the data is that exacerbations continue to be a major burden to individuals and healthcare systems, therefore, there remains great scope for other therapies to influence exacerbation frequency and preservation of quality of life. In this review, the benefits and limitations of pulmonary rehabilitation, non-invasive ventilation, smoking cessation, and long-term oxygen therapy are discussed. In addition, supported discharge, advanced care coordination, and telehealth programs to improve clinical outcome are reviewed as future directions for the management of COPD.

Citing Articles

Treatment patterns in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).

Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y Ther Adv Respir Dis. 2023; 17:17534666231158283.

PMID: 37013442 PMC: 10074631. DOI: 10.1177/17534666231158283.

Expansion of primary healthcare and emergency hospital admissions among the urban poor in Rio de Janeiro Brazil: A cohort analysis.

Hone T, Macinko J, Trajman A, Palladino R, Coeli C, Saraceni V Lancet Reg Health Am. 2023; 15:100363.

PMID: 36778075 PMC: 9904151. DOI: 10.1016/j.lana.2022.100363.

Features of a mobile health intervention to manage chronic obstructive pulmonary disease: a qualitative study.

Alwashmi M, FitzPatrick B, Davis E, Farrell J, Gamble J, Hawboldt J Ther Adv Respir Dis. 2020; 14:1753466620951044.

PMID: 32894025 PMC: 7479870. DOI: 10.1177/1753466620951044.

Uptake of telehealth implementation for COPD patients in a high-poverty, inner-city environment: A survey.

Granger C, Wijayarathna R, Suh E, Arbane G, Denehy L, Murphy P Chron Respir Dis. 2017; 15(1):81-84.

PMID: 28513197 PMC: 5802654. DOI: 10.1177/1479972317707653.

Does Telehealth Monitoring Identify Exacerbations of Chronic Obstructive Pulmonary Disease and Reduce Hospitalisations? An Analysis of System Data.

Kargiannakis M, Fitzsimmons D, Bentley C, Mountain G JMIR Med Inform. 2017; 5(1):e8.

PMID: 28330829 PMC: 5382257. DOI: 10.2196/medinform.6359.

References

Akinbami L, Liu X . Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009. NCHS Data Brief. 2011; (63):1-8. View

Zhong N, Wang C, Yao W, Chen P, Kang J, Huang S . Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007; 176(8):753-60. DOI: 10.1164/rccm.200612-1749OC. View

. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004; 59 Suppl 1:1-232. PMC: 1766028. View

Raskin J, Spiegler P, McCusker C, ZuWallack R, Bernstein M, Busby J . The effect of pulmonary rehabilitation on healthcare utilization in chronic obstructive pulmonary disease: The Northeast Pulmonary Rehabilitation Consortium. J Cardiopulm Rehabil. 2006; 26(4):231-6. DOI: 10.1097/00008483-200607000-00006. View

Donaldson G, Seemungal T, Patel I, Bhowmik A, Wilkinson T, Hurst J . Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005; 128(4):1995-2004. PMC: 7172405. DOI: 10.1378/chest.128.4.1995. View

Cazzola M, MacNee W, Martinez F, Rabe K, Franciosi L, Barnes P . Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008; 31(2):416-69. DOI: 10.1183/09031936.00099306. View

Hawkins P, Johnson L, Nikoletou D, Sherwood R, Polkey M, Moxham J . Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax. 2002; 57(10):853-9. PMC: 1746205. DOI: 10.1136/thorax.57.10.853. View

Reineck L, Kahn J . Quality measurement in the Affordable Care Act: a reaffirmed commitment to value in health care. Am J Respir Crit Care Med. 2013; 187(10):1038-9. DOI: 10.1164/rccm.201302-0404ED. View

Halpin D, Decramer M, Celli B, Kesten S, Liu D, Tashkin D . Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis. 2012; 7:653-61. PMC: 3459660. DOI: 10.2147/COPD.S34186. View

10.

Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E . Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999; 159(1):158-64. DOI: 10.1164/ajrccm.159.1.9803117. View

11.

Pitta F, Troosters T, Probst V, Spruit M, Decramer M, Gosselink R . Physical activity and hospitalization for exacerbation of COPD. Chest. 2006; 129(3):536-44. DOI: 10.1378/chest.129.3.536. View

12.

Vestbo J, Edwards L, Scanlon P, Yates J, Agusti A, Bakke P . Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011; 365(13):1184-92. DOI: 10.1056/NEJMoa1105482. View

13.

Groenewegen K, Schols A, Wouters E . Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003; 124(2):459-67. DOI: 10.1378/chest.124.2.459. View

14.

Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik M, Yohannes A . Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008; 134(4 Suppl):43S-56S. PMC: 2849676. DOI: 10.1378/chest.08-0342. View

15.

Garcia-Aymerich J, Monso E, Marrades R, Escarrabill J, Felez M, Sunyer J . Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med. 2001; 164(6):1002-7. DOI: 10.1164/ajrccm.164.6.2006012. View

16.

Cote C, Dordelly L, Celli B . Impact of COPD exacerbations on patient-centered outcomes. Chest. 2007; 131(3):696-704. DOI: 10.1378/chest.06-1610. View

17.

Barnes P, Celli B . Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009; 33(5):1165-85. DOI: 10.1183/09031936.00128008. View

18.

Ko F, Dai D, Ngai J, Tung A, Ng S, Lai K . Effect of early pulmonary rehabilitation on health care utilization and health status in patients hospitalized with acute exacerbations of COPD. Respirology. 2011; 16(4):617-24. DOI: 10.1111/j.1440-1843.2010.01921.x. View

19.

Kim H, Mofarrahi M, Hussain S . Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2009; 3(4):637-58. PMC: 2650609. DOI: 10.2147/copd.s4480. View

20.

Nici L, ZuWallack R, Wouters E, Donner C . On pulmonary rehabilitation and the flight of the bumblebee: the ATS/ERS Statement on Pulmonary Rehabilitation. Eur Respir J. 2006; 28(3):461-2. DOI: 10.1183/09031936.06.00075106. View